Fig. 2: Median Oncotype DX recurrence scores stratified by age and nodal status.
From: The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment
The A median oncotype DX recurrence score (ODX RS) and B categorized ODX RS, stratified by age group and nodal status among women with HR+/HER2–, early-stage breast cancer.
